Device based on nitinol, a process for its production, and its use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8101275
APP PUB NO 20070184277A1
SERIAL NO

11725709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a device comprising a substrate based essentially on nitinol and, arranged thereon at least partially, a covering or a coating based on at least one polyphosphazene derivative having the general formula (I), a process for its production, and the use of the device as an artificial implant, vascular or nonvascular stent, catheter, thrombolectomy or embolectomy catheter, fragmentation spindle or catheter, filter, vascular connector, hernia patch, oral, dental or throat implant or urether.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
CELONOVA BIOSCIENCES, INC.NEWNAN, GA11

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Denk, Roman Weidenstetten, DE 11 86
Grunze, Michael Neckargemünd, DE 11 256
Schüssler, Andreas Pfinztal, DE 6 9

Cited Art Landscape

Patent Info (Count) # Cites Year
 
VIRUS RESEARCH INSTITUTE, INC. (2)
5707597 Polyhalophosphazene solutions stable against gelation 9 1996
5814704 Recovery of polyphosphazene polyacids or acids salts thereof 9 1997
 
Other [Check patent profile for assignment information] (1)
5997301 Treatment of tooth surfaces and substances therefor 21 1999
 
Abbott Cardiovascular Systems Inc. (1)
* 6626937 Austenitic nitinol medical devices 74 2000
 
SOCIETE DES CERAMIQUES TECHNIQUES (1)
5238569 Filter membrane and method of manufacture 20 1992
 
ADVANCED CARDIOVASCULAR SYSTEMS, INC. (4)
5605696 Drug loaded polymeric material and method of manufacture 701 1995
6503556 Methods of forming a coating for a prosthesis 285 2000
2001/0014,717 Coating for implantable devices and a method of forming the same 230 2000
6346110 Chamber for applying therapeutic substances to an implantable device 224 2001
 
MICRO THERAPEUTICS, INC. (3)
6007573 Intracranial stent and method of use 105 1996
6432128 Intracranial stent and method of use 33 1999
6669719 Intracranial stent and method of use 106 2001
 
MENLO CARE, INC. (2)
4883699 Polymeric article having high tensile energy to break when hydrated 83 1987
4911691 Assembly for adminstering IV solution 76 1987
 
SURMODICS, INC. (1)
6254634 Coating compositions 99 1998
 
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (1)
6319984 Biodegradable and thermosensitive polyphosphazenes and their preparation method 13 2000
 
ANGIOTECH PHARMACEUTICALS, INC. (3)
5886026 Anti-angiogenic compositions and methods of use 269 1995
6506411 Anti-angiogenic compositions and methods of use 91 1999
2002/0119,202 Anti-angiogenic compositions and methods of use 22 2001
 
SCIMED LIFE SYSTEMS, INC. (2)
6569195 Stent coating 61 2001
6652575 Stent with smooth ends 136 2001
 
ANGIOTECH BIOCOATINGS CORP. (1)
5716981 Anti-angiogenic compositions and methods of use 812 1995
 
THE DOW CHEMICAL COMPANY (1)
4424395 Carbamates of biphenyls 10 1982
 
RESEARCH CORPORATION, 405 LEXINGTON AVE., NEW YORK, NY. 10174 A NOT-FOR-PROFIT CORP OF (1)
4451647 Heparinized polyorganophosphazenes 11 1982
 
NITINOL DEVELOPMENT CORPORATION (1)
* 2004/0117,001 Medical devices, particularly stents, and methods for their manufacture 6 2003
 
S.K.Y. POLYMERS, P.L., A LIMITED PARTNERSHIP OF DE (1)
4480642 Dilation device for the cervix 41 1982
 
CORDIS CORPORATION (2)
6273913 Modified stent useful for delivery of drugs along stent strut 683 1998
2002/0051,730 Coated medical devices and sterilization thereof 326 2001
 
GENZYME CORPORATION (1)
5634946 Polymeric endoluminal paving process 64 1995
 
Concentric Medical (1)
2003/0004,568 Coated combination vaso-occlusive device 46 2002
 
WYETH (7)
2001/0029,351 Drug combinations and delivery devices for the prevention and treatment of vascular disease 304 2001
2002/0005,206 Antiproliferative drug and delivery device 253 2001
2002/0111,590 Medical devices, drug coatings and methods for maintaining the drug coatings thereon 325 2001
2002/0133,183 Coated medical devices 209 2001
2003/0065,377 Coated medical devices 264 2002
2003/0204,168 Coated vascular devices 162 2002
2003/0065,345 Anastomosis devices and methods for treating anastomotic sites 177 2002
 
SUPERGEN, INC. (1)
6485514 Local delivery of therapeutic agents 21 1997
 
The Kendall Company (2)
4318947 Polymer coating and curing process for catheters 47 1981
4341844 Article having organo-phosphonitrile rubber coating bonded to natural or synthetic rubber and method of making 9 1981
 
ETHYL CORPORATION (2)
4592755 Mammary implant 49 1985
4975280 Bioerodable sustained release implants 32 1989
 
NIHON UNIVERSITY (1)
4579880 Dental cavity filling composite material 11 1984
 
MED INSTITUTE, INC. (2)
5873904 Silver implantable medical device 890 1997
* 6299604 Coated implantable medical device 778 1999
 
BOSTON SCIENTIFIC SCIMED, INC. (3)
5439446 Stent and therapeutic delivery system 347 1994
5788979 Biodegradable coating with inhibitory properties for application to biocompatible materials 410 1997
5980972 Method of applying drug-release coatings 527 1997
 
The United States of America as represented by the Secretary of the Navy (1)
5914388 Synthesis polyphosphazenes with controlled molecular weight and polydisperity 10 1997
 
TYNDALE PLAINS-HUNTER, LTD. (1)
4798876 Hydrophilic polyurethane composition 38 1985
 
PENNSYLVANIA RESEARCH CORPORATION, THE (1)
4880622 Water-soluble phosphazene polymers having pharmacological applications 53 1986
 
BASF AKTIENGESELLSCHAFT (1)
5552159 Solid depot drug form 45 1993
 
The Penn State Research Foundation (2)
5548060 Sulfonation of polyphosphazenes 33 1994
6077916 Biodegradable mixtures of polyphoshazene and other polymers 25 1998
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
COOK MEDICAL TECHNOLOGIES LLC (1)
9439787 Method of coating a stent 0 2013
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 24, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 24, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00